Cencora, Inc. (FRA:ABG)

Market Cap	56.44B
Revenue (ttm)	273.87B
Net Income (ttm)	1.32B
Shares Out	n/a
EPS (ttm)	6.78
PE Ratio	42.61
Forward PE	19.41
Dividend	2.01 (0.64%)
Ex-Dividend Date	Nov 14, 2025

Volume	10
Average Volume	59
Open	307.05
Previous Close	319.85
Day's Range	306.00 - 307.05
52-Week Range	215.10 - 327.10
Beta	n/a
RSI	74.76
Earnings Date	Feb 4, 2026

About Cencora

Cencora, Inc. sources and distributes pharmaceutical products in the United States and internationally. The company’s U.S. Healthcare Solutions segment distributes generic and injectable pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; distributes plasma and other blood products, vaccines, ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 1871
• Employees: 51,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: ABG

Financial Performance

In 2025, Cencora's revenue was $321.33 billion, an increase of 9.31% compared to the previous year's $293.96 billion. Earnings were $1.55 billion, an increase of 2.99%.

Financial numbers in USD